×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Verve Therapeutics Inc. (VERV) NASDAQ

$13.28 0.09 (0.68%)

Market Cap: $1.10B

As of 03/28/24 04:00 PM EDT. Market closed.

(VERV)

Verve Therapeutics Inc. (VERV)
NASDAQ

$13.28
0.09 (0.68%)

Market Cap: $1.10B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

verve therapeutics is a biotechnology company created with a singular focus: to protect the world from heart disease. the company brings together human genetics analysis and gene editing – two of the biggest breakthroughs in 21st century biomedicine – to develop transformative therapies for coronary heart disease. verve is developing medicines, administered once in life, to safely edit the ... read more

verve therapeutics is a biotechnology company created with a singular focus: to protect the world from heart disease. the company brings together human genetics analysis and gene editing – two of the biggest breakthroughs in 21st century biomedicine – to develop transformative therapies for coronary heart disease. verve is developing medicines, administered once in life, to safely edit the genome of adults to permanently lower ldl cholesterol and triglyceride levels and thereby treat coronary heart disease. founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, verve is backed by a top-tier syndicate of investors, including gv (formerly google ventures), arch venture partners, f-prime capital, biomatics capital, wellington management, casdin capital, and partners innovation fund. the company was recognized as a "2020 best places to work" by the boston business journal. verve is headquartered in cambridge, massachusetts. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
231
Address
.
PRICE CHART FOR VERVE THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$13.01
Previous Close
$13.19
Days Range
$12.65 - $13.24
52 week range
$8.22 - $21.42
Volume
647,690
Avg. Volume (30 days)
1,246,297
Market Cap
$1.10B
Dividend Yield
-
P/E
(5.51)
Shares Outstanding
83,619,279
Open
$13.01
Previous Close
$13.19
Days Range
$12.65 - $13.24
52 week range
$8.22 - $21.42
Volume
647,690
Avg. Volume (30 days)
1,246,297
Market Cap
$1.10B
Dividend Yield
-
P/E
(5.51)
Shares Outstanding
83,619,279
FINANCIAL STATEMENTS FOR VERVE THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR VERVE THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Yeshwant KrishnaDirectorDec 01, 2023 Buy$10.001,800,00018,000,0001,800,000Dec 05, 2023, 04:30 PM
Dorval AllisonChief Financial OfficerNov 29, 2023 Sale$11.455546,3434,060Dec 01, 2023, 04:30 PM
Bellinger AndrewCSO & CMODec 14, 2022 Option Exercise$2.8736,000103,32042,629Dec 16, 2022, 05:00 PM
Bellinger AndrewCSO & CMODec 01, 2022 Sale$22.9586519,8526,629Dec 02, 2022, 05:00 PM
Dorval AllisonChief Financial OfficerNov 29, 2022 Sale$22.1055412,2432,186Dec 01, 2022, 05:00 PM
Yeshwant KrishnaDirectorNov 04, 2022 Sale$31.1448,5831,512,8064,260,940Nov 08, 2022, 05:51 PM
GV 2017 GP, L.L.C.Member of 10% GroupNov 04, 2022 Sale$31.1448,5831,512,8064,260,940Nov 08, 2022, 05:04 PM
GV 2017 GP, L.L.C.Member of 10% GroupNov 04, 2022 Sale$31.1448,5831,512,805893Nov 08, 2022, 05:04 PM
Yeshwant KrishnaDirectorNov 03, 2022 Sale$32.7949,5681,625,4974,335,919Nov 04, 2022, 05:58 PM
Yeshwant KrishnaDirectorNov 02, 2022 Sale$35.9428,6521,029,8324,377,500Nov 04, 2022, 05:58 PM
GV 2017 GP, L.L.C.Member of 10% GroupNov 02, 2022 Sale$35.9428,6511,029,79819,302Nov 04, 2022, 04:16 PM
GV 2017 GP, L.L.C.Member of 10% GroupNov 03, 2022 Sale$32.7949,5681,625,4974,335,919Nov 04, 2022, 04:16 PM
GV 2017 GP, L.L.C.Member of 10% GroupNov 03, 2022 Sale$32.7949,5691,625,53127,290Nov 04, 2022, 04:16 PM
GV 2017 GP, L.L.C.Member of 10% GroupNov 02, 2022 Sale$35.9428,6521,029,8324,377,500Nov 04, 2022, 04:16 PM
Yeshwant KrishnaDirectorNov 01, 2022 Sale$36.7931,9631,175,8534,389,487Nov 02, 2022, 09:02 PM
Yeshwant KrishnaDirectorOct 31, 2022 Sale$38.6453,6962,074,6434,448,777Nov 02, 2022, 09:02 PM
GV 2017 GP, L.L.C.Member of 10% GroupOct 31, 2022 Sale$38.6453,6972,074,68229,965Nov 02, 2022, 04:25 PM
GV 2017 GP, L.L.C.Member of 10% GroupNov 01, 2022 Sale$36.7931,9631,175,8534,389,487Nov 02, 2022, 04:25 PM
GV 2017 GP, L.L.C.Member of 10% GroupNov 01, 2022 Sale$36.7931,9631,175,8532,637Nov 02, 2022, 04:25 PM
GV 2017 GP, L.L.C.Member of 10% GroupOct 31, 2022 Sale$38.6453,6962,074,6434,448,777Nov 02, 2022, 04:25 PM
Bellinger AndrewCSO & CMOOct 28, 2022 Option Exercise$1.4810,00014,80016,629Nov 01, 2022, 05:00 PM
Bellinger AndrewCSO & CMOOct 28, 2022 Sale$39.9010,000399,0006,629Nov 01, 2022, 05:00 PM
Kathiresan SekarChief Executive OfficerOct 03, 2022 Option Exercise$1.3950,00069,500367,839Oct 05, 2022, 05:00 PM
Kathiresan SekarChief Executive OfficerOct 03, 2022 Sale$33.6550,0001,682,622338,928Oct 05, 2022, 05:00 PM
Bellinger AndrewCSO & CMOSep 23, 2022 Option Exercise$1.4860,00088,80046,629Sep 27, 2022, 05:00 PM
Bellinger AndrewCSO & CMOSep 23, 2022 Sale$35.3460,0002,120,39219,997Sep 27, 2022, 05:00 PM
Ashe Andrew D.See RemarksAug 25, 2022 Option Exercise$1.5995,787152,217266,509Aug 29, 2022, 05:00 PM
Kathiresan SekarChief Executive OfficerAug 10, 2022 Option Exercise$1.3950,00069,500367,839Aug 11, 2022, 05:00 PM
Kathiresan SekarChief Executive OfficerAug 10, 2022 Sale$29.9050,0001,495,000317,839Aug 11, 2022, 05:00 PM
Bellinger AndrewCSO & CMOJul 20, 2022 Option Exercise$1.3920,00027,80026,629Jul 22, 2022, 05:00 PM
Bellinger AndrewCSO & CMOJul 20, 2022 Sale$34.9020,000698,0006,629Jul 22, 2022, 05:00 PM
Kathiresan SekarChief Executive OfficerJul 19, 2022 Option Exercise$1.3950,00069,500367,839Jul 21, 2022, 05:00 PM
Kathiresan SekarChief Executive OfficerJul 19, 2022 Sale$29.9050,0001,495,000317,839Jul 21, 2022, 05:00 PM
Bellinger AndrewCSO & CMOJul 13, 2022 Option Exercise$1.4810,00014,80016,629Jul 15, 2022, 05:00 PM
Bellinger AndrewCSO & CMOJul 13, 2022 Sale$24.9010,000249,0006,629Jul 15, 2022, 05:00 PM
FMR LLC10% OwnerJul 12, 2022 Sale$20.78163,0003,386,520633,729Jul 14, 2022, 05:24 PM
FMR LLC10% OwnerJul 01, 2022 Sale$15.6638,775607,216773,729Jul 06, 2022, 12:56 PM
FMR LLC10% OwnerJun 29, 2022 Sale$15.5934,409536,376821,676Jul 01, 2022, 02:54 PM
FMR LLC10% OwnerJun 30, 2022 Sale$15.2118,810286,100772,504Jul 01, 2022, 02:54 PM
ADELMAN BURT ADirectorMay 12, 2022 Buy$12.1510,000121,52618,700May 13, 2022, 04:37 PM
Kathiresan SekarChief Executive OfficerMar 18, 2022 Option Exercise$2.8769,674199,964477,525Mar 22, 2022, 07:41 AM
ADELMAN BURT ADirectorMar 15, 2022 Buy$21.384,00085,5358,700Mar 17, 2022, 07:58 AM
FMR LLC10% OwnerMar 09, 2022 Sale$29.013,971115,199825,723Mar 11, 2022, 05:59 PM
FMR LLC10% OwnerFeb 09, 2022 Sale$29.4613,190388,577829,694Feb 11, 2022, 10:40 AM
FMR LLC10% OwnerFeb 01, 2022 Sale$29.0435,5741,033,069842,884Feb 03, 2022, 11:43 AM
FMR LLC10% OwnerJan 27, 2022 Sale$29.288,983263,030878,705Jan 28, 2022, 05:04 PM
FMR LLC10% OwnerJan 26, 2022 Sale$31.23149,8534,680,3891,022,376Jan 28, 2022, 05:04 PM
Kathiresan SekarChief Executive OfficerJan 04, 2022 Option Exercise$1.391,8702,599408,406Jan 06, 2022, 04:36 PM
Kathiresan SekarChief Executive OfficerJan 04, 2022 Sale$39.901,87074,613406,536Jan 06, 2022, 04:36 PM
Kathiresan SekarChief Executive OfficerDec 27, 2021 Option Exercise$1.3942,00058,380448,536Dec 29, 2021, 04:38 PM
Kathiresan SekarChief Executive OfficerDec 28, 2021 Option Exercise$1.396,6939,303413,229Dec 29, 2021, 04:38 PM
Kathiresan SekarChief Executive OfficerDec 27, 2021 Sale$40.2042,0001,688,484412,093Dec 29, 2021, 04:38 PM
Kathiresan SekarChief Executive OfficerDec 28, 2021 Sale$39.906,693267,051406,536Dec 29, 2021, 04:38 PM
Bellinger AndrewChief Scientific OfficerDec 22, 2021 Option Exercise$1.4815,00022,20020,000Dec 27, 2021, 06:12 PM
Bellinger AndrewChief Scientific OfficerDec 22, 2021 Sale$38.7015,000580,46918,032Dec 27, 2021, 06:12 PM
Kathiresan SekarChief Executive OfficerDec 22, 2021 Option Exercise$1.3957,00079,230463,536Dec 27, 2021, 06:08 PM
Kathiresan SekarChief Executive OfficerDec 23, 2021 Option Exercise$1.3957,00079,230463,536Dec 27, 2021, 06:08 PM
Kathiresan SekarChief Executive OfficerDec 22, 2021 Sale$38.7157,0002,206,304457,662Dec 27, 2021, 06:08 PM
Kathiresan SekarChief Executive OfficerDec 23, 2021 Sale$39.9057,0002,274,300406,536Dec 27, 2021, 06:08 PM
Ashe Andrew D.See RemarksDec 02, 2021 Buy$32.104,000128,420170,722Dec 06, 2021, 08:12 AM
ADELMAN BURT ADirectorDec 02, 2021 Buy$31.344,700147,3044,700Dec 06, 2021, 08:11 AM
Redmile Group, LLC10% OwnerJun 21, 2021 Buy$19.001,050,00019,950,0001,936,530Jun 23, 2021, 04:16 PM
Logos Global Management LP10% OwnerJun 21, 2021 Buy$19.00370,0007,030,000370,000Jun 22, 2021, 05:21 PM
Rock Springs Capital Management LP10% OwnerJun 21, 2021 Buy$19.00370,0007,030,000926,298Jun 22, 2021, 05:20 PM
Beaudoin MargaretVice President, FinanceJun 21, 2021 Buy$19.001,00019,0001,000Jun 21, 2021, 06:25 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Yeshwant KrishnaDirector12/01/202318,000,000
Dorval AllisonChief Financial Officer11/29/20236,343
Bellinger AndrewCSO & CMO12/14/2022103,320
Bellinger AndrewCSO & CMO12/01/202219,852
Dorval AllisonChief Financial Officer11/29/202212,243
Yeshwant KrishnaDirector11/04/20221,512,806
GV 2017 GP, L.L.C.Member of 10% Group11/04/20221,512,806
GV 2017 GP, L.L.C.Member of 10% Group11/04/20221,512,805
Yeshwant KrishnaDirector11/03/20221,625,497
Yeshwant KrishnaDirector11/02/20221,029,832
GV 2017 GP, L.L.C.Member of 10% Group11/02/20221,029,798
GV 2017 GP, L.L.C.Member of 10% Group11/03/20221,625,497
GV 2017 GP, L.L.C.Member of 10% Group11/03/20221,625,531
GV 2017 GP, L.L.C.Member of 10% Group11/02/20221,029,832
Yeshwant KrishnaDirector11/01/20221,175,853
Yeshwant KrishnaDirector10/31/20222,074,643
GV 2017 GP, L.L.C.Member of 10% Group10/31/20222,074,682
GV 2017 GP, L.L.C.Member of 10% Group11/01/20221,175,853
GV 2017 GP, L.L.C.Member of 10% Group11/01/20221,175,853
GV 2017 GP, L.L.C.Member of 10% Group10/31/20222,074,643
Bellinger AndrewCSO & CMO10/28/202214,800
Bellinger AndrewCSO & CMO10/28/2022399,000
Kathiresan SekarChief Executive Officer10/03/202269,500
Kathiresan SekarChief Executive Officer10/03/20221,682,622
Bellinger AndrewCSO & CMO09/23/202288,800
Bellinger AndrewCSO & CMO09/23/20222,120,392
Ashe Andrew D.See Remarks08/25/2022152,217
Kathiresan SekarChief Executive Officer08/10/202269,500
Kathiresan SekarChief Executive Officer08/10/20221,495,000
Bellinger AndrewCSO & CMO07/20/202227,800
Bellinger AndrewCSO & CMO07/20/2022698,000
Kathiresan SekarChief Executive Officer07/19/202269,500
Kathiresan SekarChief Executive Officer07/19/20221,495,000
Bellinger AndrewCSO & CMO07/13/202214,800
Bellinger AndrewCSO & CMO07/13/2022249,000
FMR LLC10% Owner07/12/20223,386,520
FMR LLC10% Owner07/01/2022607,216
FMR LLC10% Owner06/29/2022536,376
FMR LLC10% Owner06/30/2022286,100
ADELMAN BURT ADirector05/12/2022121,526
Kathiresan SekarChief Executive Officer03/18/2022199,964
ADELMAN BURT ADirector03/15/202285,535
FMR LLC10% Owner03/09/2022115,199
FMR LLC10% Owner02/09/2022388,577
FMR LLC10% Owner02/01/20221,033,069
FMR LLC10% Owner01/27/2022263,030
FMR LLC10% Owner01/26/20224,680,389
Kathiresan SekarChief Executive Officer01/04/20222,599
Kathiresan SekarChief Executive Officer01/04/202274,613
Kathiresan SekarChief Executive Officer12/27/202158,380
Kathiresan SekarChief Executive Officer12/28/20219,303
Kathiresan SekarChief Executive Officer12/27/20211,688,484
Kathiresan SekarChief Executive Officer12/28/2021267,051
Bellinger AndrewChief Scientific Officer12/22/202122,200
Bellinger AndrewChief Scientific Officer12/22/2021580,469
Kathiresan SekarChief Executive Officer12/22/202179,230
Kathiresan SekarChief Executive Officer12/23/202179,230
Kathiresan SekarChief Executive Officer12/22/20212,206,304
Kathiresan SekarChief Executive Officer12/23/20212,274,300
Ashe Andrew D.See Remarks12/02/2021128,420
ADELMAN BURT ADirector12/02/2021147,304
Redmile Group, LLC10% Owner06/21/202119,950,000
Logos Global Management LP10% Owner06/21/20217,030,000
Rock Springs Capital Management LP10% Owner06/21/20217,030,000
Beaudoin MargaretVice President, Finance06/21/202119,000
Load More Insider Transactions
FUNDS WITH A POSITION IN VERVE THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ARK INVESTMENT MANAGEMENT LLC7,025,1160.58%35.08%Growth
BLACKROCK INC.4,435,4810.00158%10.93%Other
BAKER BROS. ADVISORS LP1,691,5300.27%19.41%Other
GEODE CAPITAL MANAGEMENT, LLC1,130,1630.00165%7.34%Other
PALO ALTO INVESTORS LP575,8170.72%NewOther
CANDRIAM S.C.A.310,0000.03%NewOther
D. E. SHAW & CO., INC.222,0470.0027%NewOther
FARALLON CAPITAL MANAGEMENT LLC211,2930.01%ExitedEvent Driven, Value
RENAISSANCE TECHNOLOGIES LLC164,5670.00355%NewOther
TUDOR INVESTMENT CORP ET AL31,7440.00422%ExitedEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR VERVE THERAPEUTICS INC
STOCK BUYBACKS FOR VERVE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
10.31%
1Q
12/31/2023
06/30/2023
12.55%
2Q
12/31/2023
03/31/2023
12.86%
3Q
12/31/2023
12/31/2022
13.30%
4Q
12/31/2023
09/30/2022
21.89%
5Q
12/31/2023
06/30/2022
43.26%
6Q
12/31/2023
03/31/2022
43.57%
7Q
12/31/2023
09/30/2021
45.30%
9Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
10.31%
1Q
06/30/2023
12.55%
2Q
03/31/2023
12.86%
3Q
12/31/2022
13.30%
4Q
09/30/2022
21.89%
5Q
06/30/2022
43.26%
6Q
03/31/2022
43.57%
7Q
09/30/2021
45.30%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VERVE THERAPEUTICS INC
LOADING...